title: HPV-associated head and neck cancer: a virus-related cancer epidemic.
abstract: A rise in incidence of oropharyngeal squamous cell cancer--specifically of the lingual and palatine tonsils--in white men younger than age 50 years who have no history of alcohol or tobacco use has been recorded over the past decade. This malignant disease is associated with human papillomavirus (HPV) 16 infection. The biology of HPV-positive oropharyngeal cancer is distinct with P53 degradation, retinoblastoma RB pathway inactivation, and P16 upregulation. By contrast, tobacco-related oropharyngeal cancer is characterised by TP53 mutation and downregulation of CDKN2A (encoding P16). The best method to detect virus in tumour is controversial, and both in-situ hybridisation and PCR are commonly used; P16 immunohistochemistry could serve as a potential surrogate marker. HPV-positive oropharyngeal cancer seems to be more responsive to chemotherapy and radiation than HPV-negative disease. HPV 16 is a prognostic marker for enhanced overall and disease-free survival, but its use as a predictive marker has not yet been proven. Many questions about the natural history of oral HPV infection remain under investigation. For example, why does the increase in HPV-related oropharyngeal cancer dominate in men? What is the potential of HPV vaccines for primary prevention? Could an accurate method to detect HPV in tumour be developed? Which treatment strategies reduce toxic effects without compromising survival? Our aim with this review is to highlight current understanding of the epidemiology, biology, detection, and management of HPV-related oropharyngeal head and neck squamous cell carcinoma, and to describe unresolved issues.
authors.affiliation: Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. smarur1@jhmi.edu
authors.forename: Shanthi
authors.initials: S
authors.lastname: Marur
authors.forename: Gypsyamber
authors.initials: G
authors.lastname: D'Souza
authors.forename: William H
authors.initials: WH
authors.lastname: Westra
authors.forename: Arlene A
authors.initials: AA
authors.lastname: Forastiere
mesh_terms: D014408:Biomarkers, Tumor; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000473:pathology / Q000628:therapy / Q000821:virology*; D005260:Female; D052162:Human papillomavirus 16 / Q000302:isolation & purification; D006801:Humans; D017403:In Situ Hybridization; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009959:Oropharyngeal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy / Q000821:virology*; D030361:Papillomavirus Infections / Q000150:complications* / Q000821:virology; D016133:Polymerase Chain Reaction; D012307:Risk Factors; D017678:Sex Distribution; D015996:Survival Rate; D014412:Tumor Virus Infections / Q000150:complications* / Q000821:virology
chemical_list: D014408:Biomarkers, Tumor
references.citation: Clin Cancer Res. 2009 Mar 1;15(5):1645-54
references.pmid: 19240170
references.citation: Bull Cancer. 2000 Aug;87 Spec No:48-53
references.pmid: 11082723
references.citation: J Clin Oncol. 2008 Feb 1;26(4):612-9
references.pmid: 18235120
references.citation: J Natl Cancer Inst. 2008 Mar 19;100(6):407-20
references.pmid: 18334711
references.citation: Cancer Res. 1998 Jan 1;58(1):5-13
references.pmid: 9426048
references.citation: Cancer. 2001 Dec 1;92(11):2875-84
references.pmid: 11753961
references.citation: Clin Cancer Res. 2007 Feb 15;13(4):1186-91
references.pmid: 17317828
references.citation: Oral Oncol. 2008 Mar;44(3):242-50
references.pmid: 17467327
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
references.pmid: 15734974
references.citation: Int J Cancer. 2007 Feb 15;120(4):825-32
references.pmid: 17131312
references.citation: Am J Surg Pathol. 2008 Jul;32(7):1044-50
references.pmid: 18496144
references.citation: Arch Otolaryngol Head Neck Surg. 1989 May;115(5):621-5
references.pmid: 2539843
references.citation: Acta Otolaryngol. 2005 Dec;125(12):1337-44
references.pmid: 16303684
references.citation: Oral Oncol. 2008 Oct;44(10):915-9
references.pmid: 18329326
references.citation: Int J Cancer. 2009 Jul 15;125(2):362-6
references.pmid: 19330833
references.citation: Strahlenther Onkol. 2000 Jun;176(6):278-85
references.pmid: 10897255
references.citation: Mod Pathol. 2008 Apr;21(4):376-86
references.pmid: 18223558
references.citation: J Infect Dis. 2004 Feb 15;189(4):686-98
references.pmid: 14767823
references.citation: Anticancer Res. 2005 Nov-Dec;25(6C):4375-83
references.pmid: 16334111
references.citation: Ann Oncol. 2008 Oct;19(10):1681-90
references.pmid: 18558666
references.citation: Int J Cancer. 2006 Dec 1;119(11):2620-3
references.pmid: 16991119
references.citation: IARC Monogr Eval Carcinog Risks Hum. 1991;52:1-544
references.pmid: 1683674
references.citation: Clin Cancer Res. 2008 Jan 15;14(2):366-9
references.pmid: 18223210
references.citation: N Engl J Med. 2007 May 10;356(19):1944-56
references.pmid: 17494927
references.citation: Oral Oncol. 2003 Jan;39(1):31-6
references.pmid: 12457719
references.citation: Int J Cancer. 2008 Jun 15;122(12):2656-64
references.pmid: 18360824
references.citation: Annu Rev Pathol. 2009;4:49-70
references.pmid: 18729723
references.citation: Acta Otolaryngol. 2007 Sep;127(9):988-92
references.pmid: 17712680
references.citation: J Med Virol. 2009 May;81(5):878-87
references.pmid: 19319944
references.citation: J Natl Cancer Inst. 2004 Mar 17;96(6):449-55
references.pmid: 15026470
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jan;91(1):62-9
references.pmid: 11174573
references.citation: J Clin Oncol. 2006 Sep 1;24(25):4170-6
references.pmid: 16943533
references.citation: Int J Cancer. 2007 Dec 1;121(11):2465-72
references.pmid: 17680565
references.citation: J Natl Cancer Inst. 2000 May 3;92(9):709-20
references.pmid: 10793107
references.citation: Cancer. 2005 May 1;103(9):1843-9
references.pmid: 15772957
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):7143-50
references.pmid: 18981014
references.citation: N Engl J Med. 2003 Feb 6;348(6):518-27
references.pmid: 12571259
references.citation: J Clin Oncol. 2008 Jul 1;26(19):3138-46
references.pmid: 18474879
references.citation: Radiother Oncol. 1996 Sep;40(3):197-223
references.pmid: 8940748
references.citation: Head Neck. 2009 Nov;31(11):1393-422
references.pmid: 19787782
references.citation: Int J Cancer. 2007 Jul 1;121(1):143-50
references.pmid: 17354235
references.citation: J Clin Oncol. 2008 Jul 1;26(19):3128-37
references.pmid: 18474878
references.citation: Int J Cancer. 1996 Nov 15;68(4):506-13
references.pmid: 8945623
references.citation: Oral Oncol. 2009 Sep;45(9):e85-9
references.pmid: 19457708
references.citation: Laryngoscope. 1999 Oct;109(10):1544-51
references.pmid: 10522920
references.citation: Pediatr Infect Dis J. 2007 Sep;26(9):836-40
references.pmid: 17721381
references.citation: Head Neck. 2008 Jul;30(7):898-903
references.pmid: 18383529
references.citation: Cancer. 2001 Aug 15;92(4):805-13
references.pmid: 11550151
references.citation: J Clin Oncol. 2004 Jan 1;22(1):69-76
references.pmid: 14657228
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Clin Cancer Res. 2005 Aug 15;11(16):5694-9
references.pmid: 16115905
references.citation: Cancer. 2008 Nov 15;113(10 Suppl):2901-9
references.pmid: 18980273
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2008 Apr;28(2):197-9
references.pmid: 18480997
references.citation: Oral Oncol. 2006 Jul;42(6):586-92
references.pmid: 16469526
references.citation: Oncogene. 2002 Feb 28;21(10):1510-7
references.pmid: 11896579
references.citation: Clin Cancer Res. 2000 Nov;6(11):4171-5
references.pmid: 11106228
references.citation: J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
references.pmid: 18270337
references.citation: Arch Med Res. 2008 Feb;39(2):189-97
references.pmid: 18164962
references.citation: Int J Cancer. 2004 Feb 20;108(5):766-72
references.pmid: 14696105
references.citation: J Infect Dis. 2009 May 1;199(9):1263-9
references.pmid: 19320589
references.citation: J Natl Cancer Inst. 1998 Nov 4;90(21):1626-36
references.pmid: 9811312
references.citation: Mol Oncol. 2007 Dec;1(3):350-5
references.pmid: 19383307
references.citation: Anticancer Res. 2008 Jul-Aug;28(4B):2077-80
references.pmid: 18751378
references.citation: J Cell Biochem. 2000 May;78(2):334-49
references.pmid: 10842327
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2087-96
references.pmid: 18708401
references.citation: Int J Cancer. 2005 Nov 20;117(4):605-10
references.pmid: 15929076
references.citation: Clin Cancer Res. 2003 Dec 15;9(17):6469-75
references.pmid: 14695150
references.citation: J Natl Cancer Inst. 2007 Dec 5;99(23):1801-10
references.pmid: 18042931
references.citation: Laryngoscope. 1998 Jul;108(7):1098-103
references.pmid: 9665264
references.citation: Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):93-8
references.pmid: 12504040
references.citation: Cancer. 2008 Apr 25;114(2):118-23
references.pmid: 18300234